Skip to main content
. Author manuscript; available in PMC: 2023 Jul 22.
Published in final edited form as: Am J Med. 2011 Feb;124(2):179.e1–179.e1797. doi: 10.1016/j.amjmed.2010.09.017

Table 2.

Characteristics of Residents in Intervention and Control Nursing Homes

Intervention nursing homes Control nursing homes
Total # residents on warfarin 211 224
Average % residents on warfarin 11.79 12.70
Total resident days on warfarin during the study period 55167 53601
p-value
Age Mean, SD 82.8, 9.1 82.2, 11.8 0.554
% Female 70.6 65.2 0.225
Race
 % white 90.5 78.6 0.001
 % black 3.3 11.6
 % other or unknown 6.2 9.8
Comorbidity burden (Charlson Index) Mean ± SD 2.15 ±1.59 2.44 ±1.66 0.064
Indication for warfarin
 % Atrial fibrillation 66.3 65.7 0.585
 % Venous thrombosis/pulmonary embolism 22.9 20.7
 % Stroke prevention without atrial fibrillation 8.8 12.5
 % Valvular heart disease 0.5 0.0
 % Other 4.4 5.1